Brokerages Set Ardent Health, Inc. (NYSE:ARDT) Price Target at $19.33

Ardent Health, Inc. (NYSE:ARDT) has been assigned a consensus rating of “Moderate Buy” from the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $19.30.

ARDT has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Ardent Health in a research note on Wednesday, October 8th. UBS Group assumed coverage on Ardent Health in a research note on Wednesday, September 10th. They issued a “buy” rating and a $17.00 price objective on the stock. JPMorgan Chase & Co. decreased their target price on Ardent Health from $18.00 to $15.00 and set a “neutral” rating on the stock in a report on Monday, August 11th. KeyCorp cut their price target on Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, August 7th. Finally, Bank of America lowered shares of Ardent Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th.

Ardent Health Stock Up 0.5%

Shares of NYSE:ARDT opened at $14.66 on Friday. The company’s fifty day moving average is $13.24 and its 200-day moving average is $13.09. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. Ardent Health has a 52 week low of $10.10 and a 52 week high of $19.94. The company has a market capitalization of $2.10 billion, a PE ratio of 8.10, a P/E/G ratio of 6.45 and a beta of 0.39.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Equities research analysts predict that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in Ardent Health by 368.9% during the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock worth $18,296,000 after buying an additional 1,046,845 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares during the period. Ameriprise Financial Inc. increased its position in shares of Ardent Health by 75.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after buying an additional 703,739 shares in the last quarter. SageView Advisory Group LLC increased its holdings in shares of Ardent Health by 367.2% in the second quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock worth $10,800,000 after acquiring an additional 621,430 shares in the last quarter. Finally, Nuveen LLC bought a new stake in shares of Ardent Health in the first quarter worth about $6,010,000.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.